Richard J. Whitley

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas”.

Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas

New England Journal of Medicine(2021)10.1056/nejmoa2024947

N/A

4.7DataRank · unranked

323 citations

James M. Johnston, Asim K. Bag, Joshua D. Bernstock, Rong Li, Inmaculada Aban +23 more

Azithromycin Treatment vs Placebo in Children With Respiratory Syncytial Virus–Induced Respiratory Failure

JAMA Network Open(2020)10.1001/jamanetworkopen.2020.3482

N/A

0.919DataRank · unranked

17 citations

Wei Wei Zhang, Kate Sewell, Gregory S. Gorman, Hui‐Chien Kuo, Inmaculada Aban +3 more

Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-2636

N/A

0DataRank · unranked

38 citations

Kevin A. Cassady, Justin C. Roth, Jennifer Clements, Kathleen M. Schieffer, Kristen Leraas +9 more

Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1382

N/A

0DataRank · unranked

18 citations

Joshua D. Bernstock, Stacie K. Totsch, Sam E. Gary, Abbey Rocco, Li Nan +12 more

Data from Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study

(2023)10.1158/1078-0432.c.6531350

N/A

0DataRank · unranked

0 citations

Kevin A. Cassady, Justin C. Roth, Jennifer N. Clements, Kathleen M. Schieffer, Kristen Leraas +9 more

Data from Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study

(2023)10.1158/1078-0432.c.6531350.v1

N/A

0DataRank · unranked

0 citations

Kevin A. Cassady, Justin C. Roth, Jennifer N. Clements, Kathleen M. Schieffer, Kristen Leraas +9 more

A multicenter prospective study to define the natural history of BK viral infections in kidney transplantation

Transplant Infectious Disease(2024)10.1111/tid.14237

N/A

0DataRank · unranked

11 citations

Roslyn B. Mannon, Anoma Nellore, Jo‐Anne H. Young, Alexander C. Wiseman, David J. Cohen +8 more

A randomized, placebo‐controlled, dose‐escalation phase I/II multicenter trial of low‐dose cidofovir for BK polyomavirus nephropathy

Transplant Infectious Disease(2024)10.1111/tid.14367

N/A

0DataRank · unranked

5 citations

John W. Gnann, James Rooney, V. Ram Peddi, Alexander C. Wiseman, Michelle A. Josephson +7 more

High-throughput screening for identification of influenza a inhibitors using a cell-based immunofluorescence assay

Antiviral Research(2025)10.1016/j.antiviral.2025.106209

N/A

0DataRank · unranked

0 citations

Lynn Rasmussen, N. Miranda Nebane, Sara McKellip, Dee Radzieta, Anna Manuvakhova +10 more

Synthesis of novel 6-azacytidine prodrugs as potent influenza A inhibitors

Bioorganic & Medicinal Chemistry Letters(2025)10.1016/j.bmcl.2025.130473

N/A

0DataRank · unranked

0 citations

Larry Bratton, Shuklendu D. Karyakarte, Kathy A. Keith, Yohanka Martinez-Gzegozewska, Sarath C. Sarngadharan +6 more

Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab305

N/A

0DataRank · unranked

41 citations

James M. Anderson, Annaliesa S. Anderson, David Baker, Jay Bradner, Kyle R. Brimacombe +37 more